Indication
ULCERATIVE COLITIS
2 clinical trials
3 products
Clinical trial
Intensive Treatment to Reach the Target With Golimumab in ulcErative coliTis- In-TARGETStatus: Completed, Estimated PCD: 2021-10-01
Product
GOLIMUMABClinical trial
Development of a Biomarker of Efficacy of Vedolizumab (EnTyvio®) in Patients With ulcErative ColiTis (DETECT)Status: Terminated, Estimated PCD: 2020-01-01
Product
VEDOLIZUMABProduct
ADALIMUMAB